ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,628,000 | -95.6% | 17,519 | -97.2% | 0.01% | -95.3% |
| Q3 2021 | $36,721,000 | -13.1% | 616,640 | -0.5% | 0.19% | -8.2% |
| Q2 2021 | $42,268,000 | -2.4% | 619,764 | -0.7% | 0.21% | -11.2% |
| Q1 2021 | $43,305,000 | -11.5% | 624,078 | -2.0% | 0.23% | -4.1% |
| Q4 2020 | $48,919,000 | +1.7% | 636,714 | -1.0% | 0.24% | -17.9% |
| Q3 2020 | $48,101,000 | +142.6% | 643,147 | +104.2% | 0.30% | +91.0% |
| Q2 2020 | $19,829,000 | +4005.4% | 314,998 | +2883.5% | 0.16% | +2483.3% |
| Q3 2019 | $483,000 | -24.9% | 10,558 | -3.8% | 0.01% | 0.0% |
| Q2 2019 | $643,000 | – | 10,971 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 164,300 | $9,633,000 | 4.86% |
| Atika Capital Management LLC | 230,000 | $13,485,000 | 2.65% |
| DAFNA Capital Management LLC | 93,942 | $5,508,000 | 2.07% |
| PFM Health Sciences, LP | 1,828,378 | $107,198,000 | 2.04% |
| Perceptive Advisors | 1,380,171 | $80,919,000 | 1.86% |
| Eversept Partners, LP | 73,501 | $4,309,364 | 1.21% |
| Partner Investment Management, L.P. | 18,159 | $1,065,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 170,000 | $9,967,000 | 1.10% |
| EMERALD ADVISERS, LLC | 425,510 | $24,948,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 388,418 | $22,773,000 | 0.90% |